Suchergebnisse - "Garnier, Alice"

PubPharm (15)

1

Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life

enthalten in: Annals of hematology | 2020

von Sortais, C. | Lok, A. | Tessoulin, B. | +15

2

Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide

enthalten in: Annals of hematology | 2020

von Garnier, A. | Guillaume, T. | Peterlin, P. | +14

3

Use of eltrombopag in aplastic anemia in Europe

enthalten in: Annals of hematology | 2019

von Ecsedi, M. | Lengline, �. | Knol-Bout, C. | +26

4

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study

enthalten in: Annals of hematology | 2019

von Trudel, S. | Tessoulin, B. | Jullien, M. | +14

5

Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study

enthalten in: Annals of hematology | 2019

von Jullien, M. | Trudel, S. | Tessoulin, B. | +15

6

Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?

enthalten in: European journal of haematology | 2017

von Lestang, E. | Peterlin, P. | Le Bris, Y. | +17

7

Impact of stem cell graft on early viral infections and immune reconstitution after allogeneic transplantation in adults

enthalten in: Journal of clinical virology | 2017

von Illiaquer, M. | Imbert-Marcille, B. | Guillaume, T. | +10

8

Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient

enthalten in: Annals of hematology | 2016

von Peterlin, P. | Garnier, A. | Tissot, A. | +10

9

Similarity of fractionated versus single dose(s) of gemtuzumab ozogamicin as part of the MIDAM salvage regimen in relapsed/refractory acute myeloid leukemia patients

enthalten in: Seminars in hematology | 2016

von Peterlin, P. | Guillaume, T. | Delaunay, J. | +13

10

Similarity of fractionated versus single dose(s) of gemtuzumab ozogamicin as part of the MIDAM salvage regimen in relapsed/refractory acute myeloid leukemia patients

enthalten in: Seminars in hematology | 2016

von Peterlin, P. | Guillaume, T. | Delaunay, J. | +13